The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 972.00
Bid: 958.00
Ask: 960.00
Change: 22.00 (2.32%)
Spread: 2.00 (0.209%)
Open: 946.00
High: 972.00
Low: 935.00
Prev. Close: 950.00
KNOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

4 Feb 2019 16:11

RNS Number : 0262P
Kainos Group plc
04 February 2019
 

4 February 2019

Kainos Group plc

 

("Kainos" or the "Company") 

Total Voting Rights

Pursuant to DTR 5.6.1 the Company announces that as at 1 February 2019, the total number of ordinary shares in issue now stands at 120,967,834 each with voting rights. There are no shares held in treasury.

 

The above figure (120,967,834) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Classification: 2.5 - Total number of voting rights and capital

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

 

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRQZLFBKLFFBBB
Date   Source Headline
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding
16th Mar 20167:01 amRNSKainos Evolve and InTouch Health Partnership
16th Mar 20167:00 amRNSTrading Update
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding
1st Mar 201610:00 amRNSDirector/PDMR Shareholding
11th Feb 20166:09 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNSInvestment in Cirdan Imaging Limited
27th Jan 201611:32 amRNSDirector/PDMR Shareholding
29th Dec 20152:59 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSTransfer of Shares
21st Dec 201510:00 amRNSDisposal of investment in SpeechStorm Limited
18th Dec 20152:42 pmRNSDirector/PDMR Shareholding
17th Dec 20154:46 pmRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim Results
30th Sep 201512:27 pmRNSDirector/PDMR Shareholding
15th Sep 20155:54 pmRNSDirector/PDMR Shareholding
9th Sep 20155:27 pmRNSDirector/PDMR Shareholding
7th Sep 20159:00 amRNSNotice of Results
25th Aug 20158:00 amRNSNew Mobile-Enabled healthcare platform
24th Aug 20155:31 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSHolding(s) in Company
16th Jul 20159:05 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.